Metraipolis › archive › dc_e122a8ec685e
High-fidelity SaCas9 identified by directional screening in human cells — Europe PMC PMID:32644995
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32644995
- DOI
- 10.1371/journal.pbio.3000747
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-08T05:55:05.321Z
- SHA-256 of the archived text
3213c3f740c05110620bf4af8ca16899d17063fea4b0153d71a393461b796952- Stable URL of this page
https://metraipolis.com/documento/dc_e122a8ec685e
How to cite
High-fidelity SaCas9 identified by directional screening in human cells — Europe PMC PMID:32644995 — Europe PMC (en), https://europepmc.org/article/MED/32644995 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_e122a8ec685e (Metraipolis archive dc_e122a8ec685e, sha256 3213c3f740c05110620bf4af8ca16899d17063fea4b0153d71a393461b796952)
BibTeX
@misc{dce122a8ec685e,
title = {High-fidelity SaCas9 identified by directional screening in human cells — Europe PMC PMID:32644995},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32644995},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_e122a8ec685e; sha256 3213c3f740c05110620bf4af8ca16899d17063fea4b0153d71a393461b796952},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32644995. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
CRISPR-Staphylococcus aureus Cas9 (CRISPR-SaCas9) has been harnessed as an effective in vivo genome-editing tool to manipulate genomes. However, off-target effects remain a major bottleneck that precludes safe and reliable applications in genome editing. Here, we characterize the off-target effects of wild-type (WT) SaCas9 at single-nucleotide (single-nt) resolution and describe a directional screening system to identify novel SaCas9 variants with desired properties in human cells. Using this system, we identified enhanced-fidelity SaCas9 (efSaCas9) (variant Mut268 harboring the single mutation of N260D), which could effectively distinguish and reject single base-pair mismatches. We demonstrate dramatically reduced off-target effects (approximately 2- to 93-fold improvements) of Mut268 compared to WT using targeted deep-sequencing analyses. To understand the structural origin of the fidelity enhancement, we find that N260, located in the REC3 domain, orchestrates an extensive network of contacts between REC3 and the guide RNA-DNA heteroduplex. efSaCas9 can be broadly used in genome-editing applications that require high fidelity. Furthermore, this study provides a general strategy to rapidly evolve other desired CRISPR-Cas9 traits besides enhanced fidelity, to expand the utility of the CRISPR toolkit. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS biology, 2020 (prima pubblicazione 2020-07-09). Identificativi: PMID 32644995 · PMCID PMC7347106 · DOI 10.1371/journal.pbio.3000747. Pagina: https://europepmc.org/article/MED/32644995 — https://doi.org/10.1371/journal.pbio.3000747. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-08T05:51:38.632Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.